After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $1.93 and fluctuated between $2.1000 as its day high and $1.7600 as its day low. The current market capitalization of OptiNose Inc is $217.98M. A total of 4.24 million shares were traded on the day, compared to an average of 433.11K shares.
In the most recent transaction, Mahmoud Ramy A sold 52,875 shares of OPTN for 1.31 per share on Jan 31 ’24. After the transaction, the Chief Executive Officer now owns 548,387 company shares. In a previous transaction on Dec 18 ’23, Mahmoud Ramy A sold 11,114 shares at 1.15 per share. OPTN shares that Chief Executive Officer owns now total 509,728.
Among the insiders who sold shares, Marino Michael F III disposed of 5,005 shares on Dec 18 ’23 at a per-share price of $1.15. This resulted in the Chief Legal Officer & Corp Sec holding 333,511 shares of OPTN after the transaction. In another insider transaction, Mahmoud Ramy A sold 11,083 shares at $1.37 per share on Sep 18 ’23. Company shares held by the Chief Executive Officer now total 514,729.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, OPTN has a high of $2.07 and a low of $0.90.
As of this writing, OPTN has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.08 in the last quarter, which was 11.10% higher than expectations of -$0.09.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OPTN’s latest balance sheet shows that the firm has $110.50M in Cash & Short Term Investments as of fiscal 2021. There were $130.70M in debt and $59.23M in liabilities at the time. Its Book Value Per Share was -$0.77, while its Total Shareholder’s Equity was -$21.77M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OPTN is Buy with a score of 5.00.
